Sanofi India Limited — Results, 19-03-2025: Reply to Clarification- Financial results

Sanofi India Limited has announced a board meeting to clarify discrepancies in financial results, particularly a minor error in the Earnings Per Share (EPS) figure reported as INR 40 instead of the correct INR 39.64. The board approved the Standalone and Consolidated Financial Results for the quarter and year ended December 31, 2024, reporting a profit from operations of INR 108 crores, up 21% year-on-year. The results reflect solid performance in its diabetes portfolio, despite the recent demerger of its Consumer Healthcare business. This update may foster a positive outlook among investors, showcasing operational resilience and growth potential.